Company / Working Capital
Arcellx, Inc. Working Capital History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$358.0M
FY2025
5-year range
$98.0M / $598.1M
FY2021-FY2025
Trend
-24.5%
vs FY2024
Sector context
#121 of 213
Health Care
What the data says
At $358M, Arcellx, Inc.'s working capital ranks #121 of 213 in the Health Care sector. Declined from $598M to $358M over the past 2 years.
Based on SEC 10-K filings.
$358M in FY2025 with a 3-year CAGR of +19.4%.
Declined from $598M to $358M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +19.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#121 of 213 in Health CareTop 57% of 213This company $358.0M Sector average $934.6M
▼
-61.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +19.4%, indicating consistent growth.
- In FY2025, working capital decreased 24.5% year-over-year.
- Ranks #121 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $358.0M | -24.5% |
| FY2024 | $473.9M | -20.8% |
| FY2023 | $598.1M | +184.6% |
| FY2022 | $210.2M | +114.5% |
| FY2021 | $98.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026